Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists.

Saved in:
Bibliographic Details
Title: Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists.
Authors: Helal MM; Faculty of Medicine, Zagazig University, Zagazig, Egypt., Almosilhy NA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt., Abo-Elnour DE; Faculty of Medicine, Zagazig University, Zagazig, Egypt.; Medical Research Group of Egypt, Negida Academy, Arlington, MA, USA., Jaffal RSY; Faculty of Medicine, The Hashemite University, Zarqa, Jordan., Allam EG; Faculty of Medicine, Al-Azhar University, Cairo, Egypt., Almosilhy MA; Faculty of Medicine, Menoufia University, Shibin al Kawm, Egypt., Batarseh SF; Faculty of Medicine, Jordan University of Science and Technology, Jordan, and., Meshref M; Medical Research Group of Egypt, Negida Academy, Arlington, MA, USA.; Department of Neurology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Source: Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2026 Aug; Vol. 27 (5-6), pp. 513-539. Date of Electronic Publication: 2026 Feb 12.
Publication Type: Journal Article; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101587185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2167-9223 (Electronic) Linking ISSN: 21678421 NLM ISO Abbreviation: Amyotroph Lateral Scler Frontotemporal Degener Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2167-9223
DOI:10.1080/21678421.2026.2627901